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David A. Alter, MD, PHDT he evolution and infusion of “big data” in ourabilities to track personal health informationacross multiple registries and administrative
databases longitudinally has fostered contemporary
health services and outcomes-based research world-
wide (1). Big data have been particularly useful in
evaluating social determinants of health, where
studies rely heavily on observational data. Yet, the
merits and pitfalls of using large systems of observa-
tional data to inform our understanding of socioeco-
nomic status (SES) and outcomes warrant critical
appraisal.SEE PAGE 1888With this context in mind, we should read the
study by Dalén et al. (2) with interest. This large
population-based SES-outcome study was conducted
within Sweden’s universal health care system and
explored the relationship between household dis-
posable income and all-cause mortality among
100,534 patients who underwent cardiac surgery
between 1999 and 2012. The authors used the
national registry known as SWEDEHEART (Swedish
Web-System for Enhancement and Development of
Evidence-Based Care in Heart Disease Evaluated Ac-
cording to Recommended Therapies). After adjusting
for various factors—including age, sex, birth region,
education, marital status, and comorbid diseases—
patients with household disposable incomes in the
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tents of this paper to disclose.risk for post-operative all-cause mortality compared
to their lowest household income quintile counter-
parts. The study tracked outcomes over a mean
follow-up of 7.3 years and demonstrated similar
relative income-mortality associations in early and
late post-operative time periods. The authors specu-
late that household disposable income may be
serving as a surrogate for a host of unmeasured life-
style behaviors and, accordingly, advocate for better
implementation of secondary prevention strategies
in low-income patient groups.
One of this observational study’s unique strengths
was in the use of big data to acquire individual-level
household disposable income. Utilizing their na-
tional health insurance and labor market registry,
investigators were able to determine household
disposable income (which represented taxable and
tax-free income minus ﬁnal tax and other negative
transfers) for each patient throughout multiple years
leading up to, and including, the calendar year of
surgery. While details around the accuracy and val-
idity of such data were not provided, SES information
was ascertained more rigorously than in previous
studies of similar size and scope. Historically, SES-
outcome studies have relied on either neighborhood
census data or individual self-reports to characterize
SES. Such ascertainment methods carry numerous
biases. In using actual patient-level labor market
data, Dalén et al. (2) illustrated a new application of
big data in a comprehensive population of patients.
Yet, has this study’s use of national registry data
helped to inform, unravel, or address the mysteries
underlying SES-outcome associations? Or, alterna-
tively, has this study simply reafﬁrmed associations
that we know already exist?
Dalén et al. (2) justify their study in part by
arguing that most previous research demonstrating
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1899associations between SES and mortality has done so
in populations without universal tax-ﬁnanced health
care where affordability issues may impede health
care access. While publicly funded health care pro-
grams remove signiﬁcant ﬁnancial burden, studies
have demonstrated pervasive SES-outcome differ-
ences even in the presence of universal health care.
For example, Mackenbach et al. (3) explored 22
European countries, each of which had some level of
national health insurance, using multiple national
registries, surveys, and census data to determine
socioeconomic health and outcome gradients in all
countries examined. Similarly in Canada, where all
citizens receive access to medical care without user
fees or out-of-pocket payments, SES was shown to
be independently associated with both outcomes
and utilization of specialty services (4,5). Our group
has previously demonstrated that SES-mortality as-
sociations following acute myocardial infarction
(AMI) were explained predominantly by differences
in age, baseline cardiovascular risk proﬁles, and
functional recovery during the ﬁrst year following
AMI hospitalization. In contrast, neither variations
in access, health care utilization, or quality of care
meaningfully accounted for SES-mortality associa-
tions post-AMI (6,7). In the end, many have drawn
similar conclusions to those by Dalén et al. (2), with
a focus on preventive or social health policies and
signiﬁcantly less attention on health care delivery
per se (8,9).
While some may infer that such conclusions have
demonstrated the merits of big data in helping to
inform and unravel the SES-outcome paradigm, we
should take pause. Though intuitive, the implications
of such conclusions are nontrivial, and more impor-
tantly, potentially misleading. Dalén et al.’s (2) study
once again sheds light.
Per Table 1 in Dalén et al. (2), household disposable
income correlated with several factors. For example,
the average age between lowest and highest income
quintiles differed by >7 years, which is of consider-
able magnitude for a population-based study. Age
may have directly affected income ascertainment;
income opportunities among older individuals would
have been less partly due to retirement. Additionally,
income may have been biased by “reverse causality,”
where a higher burden of symptoms and disease may
have led to lower income earnings because of greater
workforce absenteeism and disability. Patients in
lower-income quintiles were also more likely to be
women, and have achieved <10 years of education;
experienced greater social deprivation from being
single, divorced, or widowed; and had higher burden
of comorbid diseases (including pre-existing heartfailure, diabetes, and prior myocardial infarction)
than their highest-income counterparts. While the
authors used Cox proportional hazards with multi-
variable analyses, the extent to which such tradi-
tional risk-adjustment techniques can “negate” or
“adjust” for such large differences in “measured”
baseline characteristics remains debatable.
Furthermore, a myriad of other potential “unmea-
sured” confounders likely also existed and could not
be taken into account in the study, including func-
tional capacity, mobility, and depression. Moreover,
there was no information on pharmacological treat-
ments, self-management, cardiac rehabilitation, or
disease progression over time. No information was
available on patients’ behavioral risks such as smok-
ing, diet, physical activity, or health care–seeking
behaviors, to determine with certainty whether such
lifestyle preventive behaviors may be important in
the income-mortality differences observed in the
study. Short of a large natural history study that
prospectively tracks SES, behaviors, health status,
risk factors, and disease longitudinally over time,
it is unlikely that researchers would ever be able
to temporarily disentangle potential root causes
from their downstream disease sequelae. In sum,
notwithstanding the impressive data source used to
ascertain individual income, SES remains a complex
and heavily confounded variable.
Even if such data-intensive comprehensive data-
sets existed, no observational study could ever
determine the extent to which such SES-outcome
gradients were modiﬁable. Residual confounding
will always remain the “weakest link” of big data
observational research. Only interventions and clin-
ical trials can test the potential modiﬁability of
SES mortality-associated gradients. Yet, the efﬁcacy,
effectiveness, and cost effectiveness of preventive
strategies targeting lower SES groups who are less
behaviorally engaged in the self-management of their
own health remain unclear (10).
What then is the future role for big data in SES out-
comes research? First, these growing repositories of
data are uniquely positioned to evaluate the impact of
natural health-system experiments, temporal changes
in health care delivery, and public-health policy
initiatives (e.g., SES-outcome gradients before and
after antitobacco legislation). Second, big data can
contribute as a screening and surveillance tool to
identify high-risk lower SES regions, communities,
hospitals, or individuals for risk-stratiﬁcation targeted
interventions. Third, these large databases can be
further leveraged with clinical trials to improve
the efﬁciency and comprehensiveness of patient
follow-up to track outcomes. In so doing, clinical
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1900trials may be better positioned to evaluate the im-
pact of pharmacological and nonpharmacological
interventions across SES to determine if treatment
effects systematically vary between socioeconomi-
cally advantaged and disadvantaged populations.
In conclusion, observational studies using large
multilinked registries will never fully elucidate
intermediary causal mechanisms and/or the modiﬁ-
ability of SES-outcome gradients. For this to be
accomplished, researchers will require intervention-
based research and implementation science. How-
ever, as long as health systems continue to value the
importance of SES as a health equity metric, big data
will continue to play an important role in the futureof social epidemiology. The study by Dalén et al. ex-
empliﬁes the leveragability of such data for social
epidemiological health outcomes research. It is now
up to all researchers to optimize the application of
big data in order to determine the extent to which
such SES-outcome-associated gradients are modiﬁ-
able moving forward.
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